Tasman Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TASMAN PHARMA, and what generic alternatives to TASMAN PHARMA drugs are available?
TASMAN PHARMA has five approved drugs.
There is one US patent protecting TASMAN PHARMA drugs.
There are six patent family members on TASMAN PHARMA drugs in six countries and one supplementary protection certificate in one country.
Drugs and US Patents for Tasman Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tasman Pharma | KETOCONAZOLE | ketoconazole | CREAM;TOPICAL | 215185-001 | Nov 17, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tasman Pharma | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | OINTMENT;TOPICAL | 215186-001 | Feb 18, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tasman Pharma | CLOTRIMAZOLE | clotrimazole | SOLUTION;TOPICAL | 212281-001 | Jul 25, 2019 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | 8,057,811 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Tasman Pharma | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | OIL/DROPS;OTIC | 213264-001 | Feb 5, 2021 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Tasman Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Spain | 2436213 | ⤷ Try a Trial |
New Zealand | 527142 | ⤷ Try a Trial |
Australia | 2004257556 | ⤷ Try a Trial |
Canada | 2532648 | ⤷ Try a Trial |
European Patent Office | 1646393 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Tasman Pharma Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2233112 | 132014902285293 | Italy | ⤷ Try a Trial | PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.